Ruta D. Rao, MD

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

1. Adjuvant endocrine therapy for breast cancer.
   Rao RD, Cobleigh MA.
   Oncology (Williston Park). 2012
   2012 Jun
   26(6):541-7, 550, 552 passim. Review.
   
2. Patients with positive axillary lymph nodes: how to use genomic assays.
   Rao R.
   Curr Treat Options Oncol. 2012
   2012 Jun
   13(2):240-8. doi: 10.1007/s11864-012-0187-3.
   
3. Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group
   Rao RD, Cobleigh MA, Gray R, Graham ML 2nd, Norton L, Martino S, Budd GT, Ingle JN, Wood WC
   Med Oncol
   2010 Sep 28
   
4. A community effort to reduce the black/white breast cancer mortality disparity in Chicago
   Ansell D, Grabler P, Whitman S, Ferrans C, Burgess-Bishop J, Murray LR, Rao R, Marcus E
   Cancer Causes Control
   2009 Nov
   20(9):1681-8
   
5. Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy
   Chen SS, Strauss JB, Shah AP, Rao RD, Bernard DA, Griem KL
   Brachytherapy
   2009 Jul-Sep
   8(3):331-4
   
6. Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts
   Usha L, Tabesh B, Morrison LE, Rao RD, Jacobson K, Zhu A, Basu S, Coon JS
   J Hematol Oncol
   2008 Aug 14
   1:12
   

• To watch a brief video of Ruta D. Rao, MD, click the play button at the lower left corner of the video frame below.
• (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
• View Transcript

• I have a lot of patients who have very early stage breast cancer. And I have a number of patients who are survivors who had breast cancer years ago, as well as patients who are on active chemotherapy right now — and one day will become survivors — as well as patients who have metastatic disease and are living with this disease.

  You get to know a patient by knowing who’s in their family, and who’s in their social support networks. And I think, over time, we get to establish that relationship, not only with the patient, but with their children or their parents or their nieces and nephews — whoever accompanies them to their visits.

  We really take things as looking at the whole patient and looking at the different aspects of their breast cancer treatment. Between the medical oncologists, the radiation oncologists, the surgeons, and in addition we have a whole group of psychosocial oncologists in the cancer integrative medicine network to also help with that part of the patient care as well. So I think that’s one of the more unique and exciting things about how we do breast cancer care here at Rush.